首页> 外国专利> Intracoronary, intracardia, or intravenous infusion of a mixture of autologous bone marrow derived mononuclear cells and autologous bone marrow derived mesenchymal stem cells for utilization and rescue of infarcted myocardium

Intracoronary, intracardia, or intravenous infusion of a mixture of autologous bone marrow derived mononuclear cells and autologous bone marrow derived mesenchymal stem cells for utilization and rescue of infarcted myocardium

机译:自体骨髓来源的单核细胞和自体骨髓来源的间充质干细胞的混合物的冠状动脉内,心内或静脉内输注,用于心肌梗死的利用和抢救

摘要

The present invention is a method for improving cardiac function and myocardial regeneration in living subjects after the occurrence of myocardial infarction. The method is a combination stem cell therapy involving a mixture of bone marrow-derived mesenchymal stem cells and bone marrow derived mononuclear cells surgically implanted by using either a direct or catheter-mediated injection into damaged myocardium. Studies have shown that the implant improves heart function and myocardial regeneration as assessed by MRI, SPECT and echocardiographic measurements.
机译:本发明是一种在心肌梗塞发生后改善生活对象的心功能和心肌再生的方法。该方法是联合干细胞疗法,涉及通过直接或导管介导的方式将受损的心肌注射入外科手术植入的骨髓来源的间充质干细胞和骨髓来源的单核细胞的混合物。研究表明,通过MRI,SPECT和超声心动图测量评估,植入物可改善心脏功能和心肌再生。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号